+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Allergy Immunotherapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

  • ID: 5530559
  • Report
  • January 2022
  • Region: Global
  • 108 Pages
  • IMARC Group

FEATURED COMPANIES

  • Aimmune Therapeutics
  • ALK-Abello A/S
  • Allergy Therapeutics
  • Anergis SA
  • Biomay AG
  • Circassia Pharmaceuticals
The global allergy immunotherapies market reached a value of US$ 2.56 Billion in 2021. Looking forward, the publisher expects the marketto reach US$ 4.63 Billion by 2027, exhibiting a CAGR of 10.2% during 2022-2027. Keeping in mind the uncertainties of COVID-19, they are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor

Allergy immunotherapy, also known as desensitization or hypo-sensitization, is a preventive medical treatment for allergic reactions to allergens including various foods, drugs, bee venom, grass pollens and house dust mites. It alters the immune system’s response by gradually increasing the doses of the allergen. Before the treatment begins, an allergist and patient analyze triggering factors for allergy symptoms, which may involve skin and blood tests to confirm the allergens. Allergy immunotherapy helps in reducing inflammation, offering long-term impact, increasing immunological tolerance, changing the course of the disease and improving the quality of the patient’s life

In recent years, there has been a rise in the prevalence of allergies around the world on account of various environmental and lifestyle factors that influence the functioning of the immune system. With the growing awareness of allergy immunotherapies, elevating income levels and increasing healthcare expenditure, the demand for sophisticated and long-term treatment options is increasing, which in turn is stimulating the growth of the market. It is further supported by the rising clinical research and development budget owing to several initiatives undertaken by both governmental and non-governmental organizations around the world. Further, with the latest drug development technologies, pharmaceutical firms have created more efficient immunotherapies for treating an array of allergies successfully. This, coupled with advancements in the field of allergy diagnostics, is catalyzing the global allergy immunotherapies market growth


Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global allergy immunotherapies market, along with forecasts at the global and regional level from 2022-2027. Our report has categorized the market based on treatment type, allergy type and distribution channel

Breakup by Treatment Type:

Subcutaneous Immunotherapy (SCIT)
Sublingual Immunotherapy (SLIT)

Breakup by Allergy Type:

  • Allergic Rhinitis
  • Asthma
  • Food Allergy
  • Venom Allergy
  • Others

Breakup by Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Breakup by Region:

  • Europe
  • North America
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being ALK-Abello A/S, Allergy Therapeutics, Stallergenes Greer, HAL Allergy Group, DBV Technologies, Merck Group, Aimmune Therapeutics, Circassia Pharmaceuticals, Anergis SA, and Biomay AG, etc

Key Question Answered in this Report

1. What was the size of the global allergy immunotherapies market in 2021?
2. What is the expected growth rate of the global allergy immunotherapies market during 2022- 2027?
3. What are the key factors driving the global allergy immunotherapies market?
4. What has been the impact of COVID-19 on the global allergy immunotherapies market?
5. What is the breakup of the global allergy immunotherapies market based on the treatment type?
6. What is the breakup of the global allergy immunotherapies market based on the allergy type?
7. What is the breakup of the global allergy immunotherapies market based on the distribution channel?
8. What are the key regions in the global allergy immunotherapies market?
9. Who are the key players/companies in the global allergy immunotherapies market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aimmune Therapeutics
  • ALK-Abello A/S
  • Allergy Therapeutics
  • Anergis SA
  • Biomay AG
  • Circassia Pharmaceuticals

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Allergy Immunotherapies Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Treatment Type
5.5 Market Breakup by Allergy Type
5.6 Market Breakup by Distribution Channel
5.7 Market Breakup by Region
5.8 Market Forecast
6 Market Breakup by Treatment Type
6.1 Subcutaneous Immunotherapy (SCIT)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Sublingual Immunotherapy (SLIT)
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Allergy Type
7.1 Allergic Rhinitis
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Asthma
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Food Allergy
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Venom Allergy
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Hospital Pharmacy
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacy
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Pharmacy
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 Europe
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 North America
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Asia Pacific
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Middle East and Africa
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Latin America
9.5.1 Market Trends
9.5.2 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
13.1 Price Indicators
13.2 Price Structure
13.3 Margin Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 ALK-Abello A/S
14.3.2 Allergy Therapeutics
14.3.3 Stallergenes Greer
14.3.4 HAL Allergy Group
14.3.5 DBV Technologies
14.3.6 Merck Group
14.3.7 Aimmune Therapeutics
14.3.8 Circassia Pharmaceuticals
14.3.9 Anergis SA
14.3.10 Biomay AG
List of Figures
Figure 1: Global: Allergy Immunotherapies Market: Major Drivers and Challenges
Figure 2: Global: Allergy Immunotherapies Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Allergy Immunotherapies Market: Breakup by Treatment Type (in %), 2021
Figure 4: Global: Allergy Immunotherapies Market: Breakup by Allergy Type (in %), 2021
Figure 5: Global: Allergy Immunotherapies Market: Breakup by Distribution Channel (in %), 2021
Figure 6: Global: Allergy Immunotherapies Market: Breakup by Region (in %), 2021
Figure 7: Global: Allergy Immunotherapies Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 8: Global: Allergy Immunotherapies Industry: SWOT Analysis
Figure 9: Global: Allergy Immunotherapies Industry: Value Chain Analysis
Figure 10: Global: Allergy Immunotherapies Industry: Porter’s Five Forces Analysis
Figure 11: Global: Allergy Immunotherapies (Subcutaneous Immunotherapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Allergy Immunotherapies (Subcutaneous Immunotherapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Allergy Immunotherapies (Sublingual Immunotherapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Allergy Immunotherapies (Sublingual Immunotherapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Allergy Immunotherapies (Allergic Rhinitis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Allergy Immunotherapies (Allergic Rhinitis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Allergy Immunotherapies (Asthma) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Allergy Immunotherapies (Asthma) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Allergy Immunotherapies (Food Allergy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Allergy Immunotherapies (Food Allergy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Allergy Immunotherapies (Venom Allergy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Allergy Immunotherapies (Venom Allergy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Allergy Immunotherapies (Other Allergy Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Allergy Immunotherapies (Other Allergy Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Allergy Immunotherapies Market: Sales through Hospital Pharmacy (in Million US$), 2016 & 2021
Figure 26: Global: Allergy Immunotherapies Market Forecast: Sales through Hospital Pharmacy (in Million US$), 2022-2027
Figure 27: Global: Allergy Immunotherapies Market: Sales through Retail Pharmacy (in Million US$), 2016 & 2021
Figure 28: Global: Allergy Immunotherapies Market Forecast: Sales through Retail Pharmacy (in Million US$), 2022-2027
Figure 29: Global: Allergy Immunotherapies Market: Online Sales (in Million US$), 2016 & 2021
Figure 30: Global: Allergy Immunotherapies Market Forecast: Online Sales (in Million US$), 2022-2027
Figure 31: Europe: Allergy Immunotherapies Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Europe: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: North America: Allergy Immunotherapies Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: North America: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Asia Pacific: Allergy Immunotherapies Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Asia Pacific: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Middle East and Africa: Allergy Immunotherapies Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Middle East and Africa: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Latin America: Allergy Immunotherapies Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Latin America: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2022-2027
List of Tables
Table 1: Global: Allergy Immunotherapies Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Allergy Immunotherapies Market Forecast: Breakup by Treatment Type (in Million US$), 2022-2027
Table 3: Global: Allergy Immunotherapies Market Forecast: Breakup by Allergy Type (in Million US$), 2022-2027
Table 4: Global: Allergy Immunotherapies Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 5: Global: Allergy Immunotherapies Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Allergy Immunotherapies Market Structure
Table 7: Global: Allergy Immunotherapies Market: Key Players
Note: Product cover images may vary from those shown
  • ALK-Abello A/S
  • Allergy Therapeutics
  • Stallergenes Greer
  • HAL Allergy Group
  • DBV Technologies
  • Merck Group
  • Aimmune Therapeutics
  • Circassia Pharmaceuticals
  • Anergis SA
  • Biomay AG
Note: Product cover images may vary from those shown

Loading
LOADING...